NYSEAMERICAN:NAVB - Navidea Biopharmaceuticals, Inc.
$0.58
 $-0.01
-1.69%
11:45AM EDT
2019-07-22
Navidea Biopharmaceuticals, Inc. (Navidea), incorporated on April 28, 1988, is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple precision-targeted products based on the Manocept platform to help identify the sites and pathways of undetected disease and enable diagnostic accuracy, clinical decision-making, targeted treatment and patient care. The Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. The Manocept platform serves as the molecular backbone of Lymphoseek (technetium Tc 99m tilmanocept) injection, the product developed by Navidea based on the platform. Lymphoseek is a receptor-targeted, small-molecule radiopharmaceutical used in the evaluation of lymphatic basins that may have cancer involvement in patients.LymphoseekLymphoseek is a lymph node targeting radiopharmaceutical agent intended for use in intraoperative lymphatic mapping procedures and lymphoscintigraphy employed in the overall diagnostic assessment of certain solid tumor cancers. Lymphoseek is utilized with or without scintigraphic imaging, known as lymphoscintigraphy, to enable pre-operative imaging and mapping of lymph nodes to facilitate node localization during surgical procedures. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  NAVB     avg for
industry  
  avg for
sector  
42 stocks weight:  4. 94   217. 37   399. 45  
42 stocks rank:  4. 24 K 1. 27 K 716. 99  
# analyst opinions:  1. 00   13. 21   13. 71  
mean recommendation:  2. 00   2. 10   2. 04  

quick ratio:  0. 79   5. 49   1. 88  
current ratio:  0. 95   5. 87   2. 36  

target price low:  0. 64   83. 44   114. 90  
target price avg:  0. 64   106. 20   137. 90  
target price high:  0. 64   132. 30   158. 97  
1-yr high:  6. 80   111. 86   142. 57  
last close:  0. 59   86. 79   125. 44  
50-day avg:  1. 03   86. 68   122. 63  
200-day avg:  2. 83   89. 22   121. 38  
1-yr low:  0. 58   69. 78   100. 51  
volume:  152. 48 K 2. 62 M 3. 43 M
50-day avg volume:  485. 45 K 3. 20 M 4. 16 M
200-day avg volume:  147. 17 K 2. 99 M 4. 75 M

1-day return:  1. 72 % -1. 30 % -0. 99 %
this week return:  -16. 36 % 0. 45 % -0. 20 %
12-wk return:  -77. 39 % 0. 94 % 4. 84 %
52-wk return:  -86. 19 % -1. 30 % 10. 55 %

enterprise value (EV):  5. 65 M 45. 10 B 122. 38 B
market cap:  10. 66 M 38. 96 B 108. 40 B
EBITDA:  -9. 53 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -0. 59   5. 38   11. 93  
enterprise/revenue (EV/R):  5. 49   57. 92   10. 21  
total revenue:  1. 03 M 9. 91 B 39. 98 B
total debt:  1. 13 M 10. 90 B 17. 48 B
debt/equity:  1. 19 K 57. 18   120. 05  
net income (common):  -11. 85 M 2. 07 B 4. 05 B

shares outstanding:  163. 62 M 538. 09 M 1. 24 B
shares:  6. 47 M 548. 00 M 1. 22 B
shares short:  534. 13 K 10. 98 M 11. 87 M
shares short prior month:  455. 06 K 9. 32 M 12. 05 M
short ratio:  0. 84   5. 60   3. 34  
short % of float:  5. 99 % 6. 48 % 2. 64 %
total cash/share:  0. 21   10. 98   9. 19  
total cash:  2. 07 M 5. 93 B 6. 10 B
free cash flow:  704. 17 K 2. 92 B 4. 55 B
operating cash flow:  4. 37 M 3. 80 B 5. 78 B

book value:  -0. 06   13. 35   27. 45  
price/book:  -10. 35   4. 60   8. 78  
gross profits:  1. 07 M 7. 44 B 36. 13 B
operating margins:  -940. 94 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  90. 04 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -1. 31   2. 10   4. 23  
forward EPS:  -0. 03   3. 45   7. 10  
P/E:  -0. 45   1. 90   32. 10  
forward P/E:  -19. 67   6. 46   15. 47  
PE/G:  0. 01   0. 70   -0. 54  
growth:  -50. 80 % 265. 63 % 79. 11 %
earnings high:  -0. 00   0. 89   1. 68  
earnings avg:  -0. 00   0. 70   1. 57  
earnings low:  -0. 00   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -51. 98 % -2. 34 % 5. 28 %
return on equity:  -469. 73 % -90. 08 % 133. 53 %
revenue growth:  -50. 80 % 265. 25 % 73. 68 %
revenue/share:  0. 11   12. 72   60. 04  

beta (1yr vs S&P500):  1. 12   1. 27   0. 91  
sharpe (1yr):  -0. 82   0. 16   0. 77  

held % insiders:  21. 79 % 6. 06 % 3. 29 %
held % institutions:  4. 85 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : NAVB
.    100.845 =       100.845 :: --> INITIAL WEIGHT <--
.    - 1.311 =        99.534 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.953 =       194.389 :: P/E factor
.    x 2.209 =       429.397 :: PE/G factor
.    x 1.413 =       606.933 :: beta factor
.    x 0.935 =       567.355 :: sharpe factor
.    x 2.161 =      1226.176 :: current ratio factor
.    x 1.808 =      2217.181 :: quick ratio factor
.    x 1.532 =      3396.918 :: short ratio factor
.    x 1.095 =      3718.757 :: EV/R factor
.    x 0.968 =      3601.431 :: debt-to-revenue factor
.    x 2.658 =      9572.937 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     20302.218 :: sector+industry 1-year gains factor
.    x 1.009 =     20493.629 :: industry 12-weeks return factor
.    x 1.308 =     26803.383 :: industry 2-weeks return factor
.    x 0.946 =     25361.299 :: "drift" penalty 4 days ago
.    / 2.252 =     11261.785 :: overall "drift" factor
.    x 0.488 =      5497.365 :: largest single-day jump factor
.     x 0.06 =       331.366 :: low price factor
.    x 1.273 =       421.689 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.001 =          0.38 :: forward EPS factor
.    x 0.637 =         0.242 :: forward P/E factor
.    x 1.185 =         0.286 :: industry recommendation factor
.    x 2.068 =         0.592 :: company recommendation factor
.    x 1.003 =         0.594 :: factor historical industry gain for week 29
.    x 8.779 =         5.215 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         1.511 :: reduced for readability
.    + 3.427 =         4.938 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      4.938 :: FINAL WEIGHT for NYSEAMERICAN:NAVB


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org